# A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole

> **NCT03314298** · PHASE1 · COMPLETED · sponsor: **Havah Therapeutics Pty Ltd** · enrollment: 11 (actual)

## Conditions studied

- Mammographic Density

## Interventions

- **DRUG:** testosterone anastrozole

## Key facts

- **NCT ID:** NCT03314298
- **Lead sponsor:** Havah Therapeutics Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-14
- **Primary completion:** 2018-04-17
- **Final completion:** 2018-04-17
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314298, "A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03314298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*